Chromocell Therapeutics Corporation (CHRO) — Working Capital to Net Assets Ratio
Chromocell Therapeutics Corporation (CHRO) has a Working Capital to Net Assets ratio of 100.0% as of June 2025. Working capital of $-6.49 Million (current assets of $822.85K minus current liabilities of $7.32 Million) is measured against net assets of $-6.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Chromocell Therapeutics Corporation assets under control.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Chromocell Therapeutics Corporation Working Capital to Net Assets (2020–2024)
This chart shows how Chromocell Therapeutics Corporation's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2020 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting working capital of $-6.49 Million against net assets of $-6.49 Million USD. Explore Chromocell Therapeutics Corporation (CHRO) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Working Capital to Net Assets for Chromocell Therapeutics Corporation (2020–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Chromocell Therapeutics Corporation from 2020 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read how much debt does Chromocell Therapeutics Corporation carry for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.0% | $-2.71 Million | $-2.71 Million | $1.37 Million | $4.08 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $-6.44 Million | $-6.44 Million | $96.39K | $6.54 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $-6.44 Million | $-6.44 Million | $96.39K | $6.54 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $-3.71 Million | $-3.71 Million | $55.07K | $3.76 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $-3.71 Million | $-3.71 Million | $55.07K | $3.76 Million | ▲ +29.9 pp |
| 2021 | 70.1% | $-2.58 Million | $-3.68 Million | $0.00 | $2.58 Million | ▲ +0.0 pp |
| 2021 | 70.1% | $-2.58 Million | $-3.68 Million | $0.00 | $2.58 Million | ▼ -29.9 pp |
| 2020 | 100.0% | $-3.58 Million | $-3.58 Million | $71.87K | $3.65 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $-3.58 Million | $-3.58 Million | $71.87K | $3.65 Million | — |